SCHEMBL7356138

SCHEMBL7356138

CC(C)=C1Oc2cccc(OCC#CCN3CCC(NC(=O)c4ccc(Br)cc4)CC3)c2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 2/20 0.38
HTR7 P34969 2/20 0.37
HTR1A P08908 1/20 0.37
UTS2R Q9UKP6 2/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
LMNA P02545 3/20 0.36
ALDH1A1 P00352 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SLC6A12 P48065 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
MCHR1 Q99705 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
CARM1 Q86X55 1/20 0.35
PRMT6 Q96LA8 1/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7352709 0.93 HTR7 (0.45) DRD4HTR7HTR1ACYP2D6ALDH1A1
SCHEMBL7345537 0.91 SLC6A5 (0.44) DRD4HTR7HTR1A
SCHEMBL7346919 0.89 UTS2R (0.42) DRD4HTR7HTR1AUTS2RKMT2A
SCHEMBL6461236 0.86 HTR7 (0.46) DRD4HTR7HTR1AUTS2RCARM1
SCHEMBL7346054 0.85 CNR2 (0.40) HTR7HTR1AUTS2RLMNAKMT2A
SCHEMBL7351795 0.84 HTR7 (0.44) DRD4HTR7HTR1AUTS2RCYP2D6
SCHEMBL7350951 0.83 DRD4 (0.47) DRD4KMT2ASLC6A12TMEM97MCHR1
SCHEMBL6462987 0.79 HTR7 (0.47) HTR7HTR1ACYP2D6CYP2C19LMNA
SCHEMBL6466592 0.79 HTR7 (0.55) HTR7HTR1ASLC6A12TMEM97MCHR1
SCHEMBL6457124 0.79 ADRA1D (0.50) DRD4HTR7HTR1ACYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6307051-B1 UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTAGONISTS AND HAVE ANTITUMOR AND ANTIMETASTATIC ACTIVITY. ROCHE DIAGNOSTICS GMBH (DE) 2001-10-23 US disclosed
EP-1026165-A1 O-substituted Hydroxycoumaranone derivatives as antitumor and antimetastatic agents Roche Diagnostics GmbH (DE) 2000-08-09 EP disclosed